Table 2.
Candidate | Pattern of inheritance | Phenotype | Frequency in IHH patients | Digenicity |
---|---|---|---|---|
KAL-1 (Anosmin) | X-linked | Anosmic, complete penetrance | 5-10% | Yes |
FGF8 (KAL-6) | AD | Anosmic, normosmic NRP, FPP | 2% | Yes |
FGFR1 (KAL-2) | AD | Variable expressivity AP, DP, PP | 10% | Yes |
PROK2 (KAL-4) | AD, AR | Anosmic, normosmic Incomplete penetrance | 2% | Yes |
PROKR2 (KAL-3) | AD, AR | Anosmic, normosmic Incomplete penetrance | 4% | Yes |
CHD7 (KAL-5) | AD | Anosmic, normosmic CHARGE syndrome | 5% | Not reported |
NELF | AR | Hyposmic | <1% | Yes |
KISSR (GPR54) | AR | Normosmic | 2% | No |
Axl | sporadic | Anosmic,normosmic | ? | Yes |
AD-autosomal dominant; AR-autosomal recessive; AP-absent puberty, DP-delayed puberty, DP-delayed pubery, NRP-normal reproductive phenotype, FPP-fully penetrant phenotype
CHARGE syndrome: coloboma, heart abnormalities, choanal atresia, retardation of growth and development, genital hypoplasia and ear abnormalities
KAL 1 – Kallmann 1; FGF8- Fibroblast growth factor 8; FGFR1- Fibroblast growth factor receptor 1; PROK2-Prokineticin 2; PROKR2-Prokineticin 2 receptor; CHD7- Chromodomain helicase DNA binding protein 7; NELF- Nasal embryonic LHRH factor; KISSR- Kisspeptin receptor